" class="no-js "lang="en-US">
Home » People » Dr. Colin Hayward
Dr. Colin Hayward
Chief Medical Officer Biotech / Oncology / CRO
December 22 2022
Telix Pharmaceuticals has announced that the completed pivotal Phase III ZIRCON study of TLX250-CDx in […]
November 22 2022
Telix Pharmaceuticals has announced that a first patient has been dosed in a Phase II […]
Join Our Newsletter.
Subscribe to receive email updates from PTF.